Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IPEX”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07697118
What this trial is testing

Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like.

Who this might be right for
The Immune Dysregulation Polyendocrinopathy Enteropathy X-linked Syndrome is a Primary Immunodeficiency Caused by Pathogenic Variants in Forkhead Box Protein 3
Assistance Publique - Hôpitaux de Paris 5
Not applicableStudy completedNCT01443013
What this trial is testing

Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient

Who this might be right for
Function of Renal Transplant
Assistance Publique - Hôpitaux de Paris 266
Testing effectiveness (Phase 2)UnknownNCT01446484
What this trial is testing

Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

Who this might be right for
End-Stage Renal DiseaseKidney Failure
Pirogov Russian National Research Medical University 30
Early research (Phase 1)Looking for participantsNCT05241444
What this trial is testing

CD4^LVFOXP3 in Participants With IPEX

Who this might be right for
IPEX
Bacchetta, Rosa, MD 30
Testing effectiveness (Phase 2)Looking for participantsNCT07284641
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Who this might be right for
Common Variable Immunodeficiency (CVID)Primary Immune Regulatory DisorderImmune Dysregulation+12 more
Paul Szabolcs 25
Testing effectiveness (Phase 2)Study completedNCT01998633
What this trial is testing

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Who this might be right for
Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus InfectionChronic Granulomatous Disease+3 more
Medical College of Wisconsin 47
Post-approval studies (Phase 4)Study completedNCT04472481
What this trial is testing

Vitamin D Effect in Rheumatoid Arthritis.

Who this might be right for
Active Rheumatoid Arthritis
Tanta University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01821781
What this trial is testing

Immune Disorder HSCT Protocol

Who this might be right for
Immune Deficiency DisordersSevere Combined ImmunodeficiencyChronic Granulomatous Disease+11 more
Washington University School of Medicine 20
Testing effectiveness (Phase 2)WithdrawnNCT06030037
What this trial is testing

Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

Who this might be right for
PD-1 Refractory Advanced Melanoma
Diwakar Davar
Not applicableStudy completedNCT02779881
What this trial is testing

Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy

Who this might be right for
Cow's Milk Allergy
Federico II University 40
Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Not applicableUnknownNCT01513408
What this trial is testing

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 500
Large-scale testing (Phase 3)Study completedNCT06281353
What this trial is testing

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

Who this might be right for
Anogenital Wart
Universitas Indonesia 78
Not applicableNot Yet RecruitingNCT07535125
What this trial is testing

IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN

Who this might be right for
Intraductal Papillary Mucinous NeoplasmsPancreatic Exocrine Insufficiency
A.O.U. Città della Salute e della Scienza 600
Post-approval studies (Phase 4)Study completedNCT01538485
What this trial is testing

Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT

Who this might be right for
Immune Tolerance
Medical University of Graz 16
Large-scale testing (Phase 3)UnknownNCT01951898
What this trial is testing

Effects of Montelukast on Airway Regulatory T Cells in Asthma

Who this might be right for
Asthma
Kurume University 15
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableActive Not RecruitingNCT06659068
What this trial is testing

Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Universitas Sriwijaya 40
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Next Page